This interaction between the gut microbiota and AhR represents a promising therapeutic avenue for the treatment or prevention of AD, suggesting that modulation of the microbiota through dietary or pharmacological interventions could potentially mitigate the neuroinflammatory processes that contribute to the disease. Here, AHR is linked to Alzheimer disease.